Lyon Civilian Hospices
Melanoma incidence is increase in global population and number of transplantation also. However immunosuppressor increase recurrence risk of melanoma. There are more and more cases of eligible patients to transplant with an antecedent of melanoma. There is no guideline yet. Main objective is survival time without melanoma recurrence in this population to do guideline of time limit or not between melanoma and transplantation by stage.
Malignant Melanoma
patient with melanoma pre transplantation
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 37 participants |
| Official Title : | Pre Transplantation Melanoma : Retrospective and Prospective Multicenter Observational Study |
| Actual Study Start Date : | 2020-02-27 |
| Estimated Primary Completion Date : | 2020-08-31 |
| Estimated Study Completion Date : | 2020-08-31 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
DERMATOLOGY SERVICE - EDOUARD HERRIOT HOPITAL
Lyon, Rhone, France, 69003